This compilation includes all of our research to-date on the coronavirus. High frequency charts on infection, mortality, economic and market data are updated as data becomes available, usually on a daily basis.
What’s new: Early tracking of variants and vaccine efficacy (Section 4); Vaccination update by country and US state (Section 4); Reinfection risks in previously infected populations (Section 5).
Our research to-date on the coronavirus: |
1. US spending, mobility, and production tracker
- High frequency tracking (manufacturing, retail, air travel, geolocation, oil, hotels, housing, etc.)
- Office utilization rates and mobility
- Real time credit and debit spending data
2. COVID global infection, hospitalization and mortality tracker
- Commentary and charts on the latest COVID trends by country and region
- Global and regional snapshots, comparisons of largest countries and US states
- How lethal is COVID, and for whom?
3. COVID tracker: countries and states
- Country and state specific charts on Infection, hospitalization and mortality
- Early tracking of variants and vaccine efficacy
- Where does herd immunity kick in?
- Vaccination update by country and US state
- How mRNA vaccines, vector vaccines and traditional vaccine types work
5. COVID: reinfection, antibodies, T-cell immune memory and survivor impacts
- Reinfection risks in previously infected populations
- COVID health impacts on survivors
- How virus testing and antibody testing work
- Pre-existing T-cell immune memory and COVID
- The issue of falling antibody levels in convalescing patients
- The latest news on anti-virals, monoclonal antibodies, convalescent plasma and corticosteroids
This compilation incorporates research and feedback from the Johns Hopkins University Center for Health Security, Harvard Medical School, the University of Toronto Dalla Lana School of Public Health, Washington University Biomedical Sciences Department, the La Jolla Institute for Immunology, the Imperial College of London Department of Infectious Disease Epidemiology and the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.
0903c02a8283f910
